Work

Pretransplant treatments for hepatocellular carcinoma: Do they improve outcomes?

Year: 2005

Type: article

Abstract: 1. Locoregional ablative treatments are commonly performed for heptocellular carcinoma (HCC) in patients awaiting transplantation, either to prevent the patient becoming untransplantable due to tumor growth or to prevent tumor recurrence post-operatively. 2. Although these treatments are quite effective at tumor destruction, there is no clear evidence that they improve patient outcomes. 3. Prospective, randomized controlled trials are clearly needed to determine if pre-transplant therapy of HCC is of value.

Source: Liver Transplantation

DOI: 10.1002/lt.20598

Author: Adrian M. Di Bisceglie

Institution: Saint Louis University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $2,150